Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9444930rdf:typepubmed:Citationlld:pubmed
pubmed-article:9444930lifeskim:mentionsumls-concept:C0022567lld:lifeskim
pubmed-article:9444930lifeskim:mentionsumls-concept:C0079460lld:lifeskim
pubmed-article:9444930lifeskim:mentionsumls-concept:C0018270lld:lifeskim
pubmed-article:9444930lifeskim:mentionsumls-concept:C1948023lld:lifeskim
pubmed-article:9444930pubmed:issue4lld:pubmed
pubmed-article:9444930pubmed:dateCreated1998-3-5lld:pubmed
pubmed-article:9444930pubmed:abstractTextHuman granulocyte-macrophage colony stimulating factor (GM-CSF) is a 22 kD glycoprotein derived from activated T cells, endothelial cells, fibroblasts and macrophages. It stimulates the proliferation and differentiation of haematopoietic cells and certain nonhaematopoietic cells. This study investigated the effect of GM-CSF on cultured human keratinocytes and determined whether these cells express GM-CSF receptors. Measurement of keratinocyte growth by image analysis showed that GM-CSF mildly stimulated the growth of keratinocytes. With 4 ng/ml GM-CSF the growth of primary keratinocytes and subcultured keratinocytes was only stimulated up to 25% and 18% of the control cell level, respectively. Human keratinocytes were incubated with GM-CSF at 4 ng/ml for 4 days to induce receptor expression. These cells showed only a weak positive reaction on affinity labelling using digoxigenated GM-CSF. We conclude that keratinocyte growth may be stimulated by GM-CSF but that the presence of GM-CSF receptors on these cells is equivocal.lld:pubmed
pubmed-article:9444930pubmed:languageenglld:pubmed
pubmed-article:9444930pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9444930pubmed:citationSubsetIMlld:pubmed
pubmed-article:9444930pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9444930pubmed:statusMEDLINElld:pubmed
pubmed-article:9444930pubmed:monthDeclld:pubmed
pubmed-article:9444930pubmed:issn0022-9717lld:pubmed
pubmed-article:9444930pubmed:authorpubmed-author:MarksRRlld:pubmed
pubmed-article:9444930pubmed:authorpubmed-author:TanakaMMlld:pubmed
pubmed-article:9444930pubmed:authorpubmed-author:DykesP JPJlld:pubmed
pubmed-article:9444930pubmed:issnTypePrintlld:pubmed
pubmed-article:9444930pubmed:volume46lld:pubmed
pubmed-article:9444930pubmed:ownerNLMlld:pubmed
pubmed-article:9444930pubmed:authorsCompleteYlld:pubmed
pubmed-article:9444930pubmed:pagination184-7lld:pubmed
pubmed-article:9444930pubmed:dateRevised2008-8-7lld:pubmed
pubmed-article:9444930pubmed:meshHeadingpubmed-meshheading:9444930-...lld:pubmed
pubmed-article:9444930pubmed:meshHeadingpubmed-meshheading:9444930-...lld:pubmed
pubmed-article:9444930pubmed:meshHeadingpubmed-meshheading:9444930-...lld:pubmed
pubmed-article:9444930pubmed:meshHeadingpubmed-meshheading:9444930-...lld:pubmed
pubmed-article:9444930pubmed:meshHeadingpubmed-meshheading:9444930-...lld:pubmed
pubmed-article:9444930pubmed:meshHeadingpubmed-meshheading:9444930-...lld:pubmed
pubmed-article:9444930pubmed:year1997lld:pubmed
pubmed-article:9444930pubmed:articleTitleKeratinocyte growth stimulation by granulocyte-macrophage colony-stimulating factor (GM-CSF).lld:pubmed
pubmed-article:9444930pubmed:affiliationDepartment of Dermatology, University of Wales College of Medicine, Cardiff, UK. kdtanaka@med.keio.ac.jplld:pubmed
pubmed-article:9444930pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9444930pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed